Added to YB: 2026-01-12
Pitch date: 2026-01-01
SNN [neutral]
Smith & Nephew plc
+1.7%
current return
Author Info
No bio for this author
Company Info
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
Market Cap
GBP 14.4B
Pitch Price
GBP 12.33
Price Target
N/A
Dividend
2.25%
EV/EBITDA
11.58
P/E
30.30
EV/Sales
2.88
Sector
Health Care Equipment and Supplies
Category
turnaround
Theodosian Capital | End of Year Review 2025 - Smith & Nephew plc
SNN (holding update): Shares +25% in 2025 as transformation benefits emerged. Upgraded 2025 guidance to 19.5%+ trading margin & ~$800M FCF. New RISE plan targets 6-7% revenue CAGR, 9-10% trading profit CAGR, $1B FCF by 2028, 12-13% ROIC vs >9% in 2025. Trades 13.8x PE, 2.9% yield.
Read full article (1 min)